Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.
Meis OmranLennart BlomqvistYvonne BrandbergNiklas PalPer KognerAnne Kinhult StåhlbomEmma ThamSvetlana Bajalica LagercrantzPublished in: Hereditary cancer in clinical practice (2020)
Trial registration number: ISRCTN13103571, retrospectively registered on 14/10/2019.